Xian-long Meng
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer.
Journal: Clinical and translational medicine
Published: October 13, 2024
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors.
Journal: Journal of translational medicine
Published: April 14, 2024
The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion.
Journal: Hepatology international
Published: August 17, 2022
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Journal: Signal transduction and targeted therapy
Published: August 11, 2022
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Journal: Nature communications
Published: August 08, 2022
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Journal: Frontiers in immunology
Published: May 05, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026